stocknews5d
3 Defensive Stocks to Buy Before the Next Market Crash
Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...
stocknews10d
3 Dividend Aristocrats With Consistent Payouts
Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...
Renal & Urology News19d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Approval of Spravato, granted following FDA priority review, was based on the results ... compared with 7.6% of patients taking placebo. Spravato nasal spray is administered by the patient under ...
Too Old to Operate23d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Approval of Spravato, granted following FDA priority review, was based on the results of a randomized ... compared with 7.6 percent of patients taking placebo. Spravato nasal spray is administered by ...
New York Post23d
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
Yahoo Finance23d
J&J’s Spravato receives FDA label expansion for depression monotherapy
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine ... this label expansion follows a priority review from the FDA. The approval was based on data from the Phase IV TRD4005 study ...
KTVU23d
FDA approves first-of-its-kind nasal spray to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...